CAS 1952316-43-6

Formula: C26H23N7O2

InChI: InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m1/s1

InChI key: WDENQIQQYWYTPO-LJQANCHMSA-N

SMILES: CC#CC(=O)N1CCC[C@@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5

Acalabrutinib enantiomer

CAS: 1952316-43-6

R-Acalabrutinib, a BTK inhibitor,enantiomer, is researched for cancer, autoimmune diseases, and inflammation.

Formula: C₂₆H₂₃N₇O₂

Purezza: 99.20%

Colore e forma: Solid

Peso molecolare: 465.51

Ref: TM-T67881

(R)-4-(8-Amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide

CAS: 1952316-43-6

Purezza: 97.27%

Ref: IN-DA00AR3D

Acalabrutinib enantiomer

CAS: 1952316-43-6

Acalabrutinib enantiomer

Formula: C₂₆H₂₃N₇O₂

Purezza: ≥95%

Peso molecolare: 465.51

Ref: 54-BUP12133

R-Acalabrutinib

CAS: 1952316-43-6

Formula: C₂₆H₂₃N₇O₂

Peso molecolare: 465.52

Ref: 4Z-A-001018

Acalabrutinib R-Isomer

CAS: 1952316-43-6

Formula: C₂₆H₂₃N₇O₂

Peso molecolare: 465.52

Ref: ST-EA-CP-A165013